Characteristic | EG(n = 119) | CG(n = 98) | p -value |
---|---|---|---|
Histology | 0.840 | ||
 Squamous | 109 | 89 |  |
 Adenocarcinoma | 10 | 9 |  |
Median age, y (range) | 54(35–78) | 54(32–78) | 0.428 |
Chemotherapy | Â | Â | 0.394 |
 Paclitaxel + Cisplatin | 108 | 92 |  |
 Paclitaxel + Carboplatin | 11 | 6 |  |
FIGO stage | Â | Â | 0.229 |
 IIb | 36 | 20 |  |
 IIIb | 13 | 14 |  |
 IIIc1 | 54 | 42 |  |
 IIIc2 | 9 | 15 |  |
 IVa | 7 | 7 |  |
Maximum tumor diameter (cm) | 4.42 ± 0.94 | 4.51 ± 1.56 | 0.636 |
Pretreatment hemoglobin (g/L) | 114.59 ± 17.10 | 112.87 ± 16.34 | 0.452 |